PFREUNDSCHUH PETER P.
Insider CIK 1585839 · SCMP CFO · VYGR Chief Financial Officer · URGN Chief Financial Officer · FREQ Chief Financial Officer · YMAB EVP, CFO and Treasurer · IMMU Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 15,900 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 15,900 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 63,500 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer deriv | 2025-09-16 | 2025-09-18 | 170,000 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | D To issuer | 2025-09-16 | 2025-09-18 | 77,800 | — | $0 | 0 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2025-01-17 | 2025-01-22 | 63,500 | — | $0 | 63,500 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award | 2025-01-17 | 2025-01-22 | 31,800 | — | $0 | 77,800 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award deriv | 2024-07-12 | 2024-07-12 | 170,000 | — | $0 | 170,000 | SEC↗ |
| YMAB Y-mAbs Therapeutics, Inc. | A Award | 2024-07-12 | 2024-07-12 | 46,000 | — | $0 | 46,000 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2024-02-21 | 2024-02-22 | 3,764 | $7.46 | $28.1K | 175,669 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2024-02-09 | 2024-02-16 | 60,000 | — | $0 | 60,000 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award | 2024-02-09 | 2024-02-16 | 30,000 | — | $0 | 179,433 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | S Sale | 2023-10-03 | 2023-10-05 | 13,567 | $6.99 | $94.8K | 149,433 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2023-02-17 | 2023-02-22 | 76,000 | — | $0 | 76,000 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award | 2023-02-17 | 2023-02-22 | 38,000 | — | $0 | 163,000 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award | 2022-10-01 | 2022-10-04 | 125,000 | — | $0 | 125,000 | SEC↗ |
| VYGR Voyager Therapeutics, Inc. | A Award deriv | 2022-09-19 | 2022-09-21 | 200,000 | — | $0 | 200,000 | SEC↗ |
| FREQ Frequency Therapeutics, In | S Sale | 2022-02-22 | 2022-02-23 | 1,542 | $3.53 | $5.4K | 8,927 | SEC↗ |
| FREQ Frequency Therapeutics, In | S Sale | 2022-02-18 | 2022-02-23 | 1,404 | $3.88 | $5.4K | 10,469 | SEC↗ |
| FREQ Frequency Therapeutics, In | A Award deriv | 2022-02-17 | 2022-02-18 | 150,000 | — | $0 | 150,000 | SEC↗ |
| FREQ Frequency Therapeutics, In | S Sale | 2022-02-17 | 2022-02-18 | 1,296 | $4.20 | $5.4K | 11,873 | SEC↗ |
| FREQ Frequency Therapeutics, In | S Sale | 2022-02-16 | 2022-02-18 | 1,229 | $4.43 | $5.4K | 13,169 | SEC↗ |
| FREQ Frequency Therapeutics, In | S Sale | 2022-02-15 | 2022-02-16 | 1,347 | $4.33 | $5.8K | 14,398 | SEC↗ |
| FREQ Frequency Therapeutics, In | M Exercise deriv | 2022-02-14 | 2022-02-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| FREQ Frequency Therapeutics, In | M Exercise | 2022-02-14 | 2022-02-16 | 15,000 | — | $0 | 15,745 | SEC↗ |
| FREQ Frequency Therapeutics, In | A Award deriv | 2021-04-20 | 2021-04-22 | 30,000 | — | $0 | 30,000 | SEC↗ |
| FREQ Frequency Therapeutics, In | A Award deriv | 2021-01-15 | 2021-01-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FREQ Frequency Therapeutics, In | A Award deriv | 2020-12-02 | 2020-12-03 | 230,000 | — | $0 | 230,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2020-10-15 | 2020-10-16 | 2,000 | — | $0 | 4,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2020-10-15 | 2020-10-16 | 2,084 | — | $0 | 2,082 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2020-10-15 | 2020-10-16 | 833 | — | $0 | 1,667 | SEC↗ |
| URGN UroGen Pharma Ltd. | S Sale | 2020-10-15 | 2020-10-16 | 976 | $21.80 | $21.3K | 11,829 | SEC↗ |
| URGN UroGen Pharma Ltd. | S Sale | 2020-10-15 | 2020-10-16 | 407 | $21.82 | $8.9K | 11,422 | SEC↗ |
| URGN UroGen Pharma Ltd. | S Sale | 2020-10-15 | 2020-10-16 | 1,017 | $21.72 | $22.1K | 10,405 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2020-10-15 | 2020-10-16 | 4,917 | — | $0 | 12,805 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2020-09-01 | 2020-09-01 | 1,042 | — | $0 | 4,166 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2020-09-01 | 2020-09-01 | 1,042 | — | $0 | 8,397 | SEC↗ |
| URGN UroGen Pharma Ltd. | S Sale | 2020-09-01 | 2020-09-01 | 509 | $22.82 | $11.6K | 7,888 | SEC↗ |
| URGN UroGen Pharma Ltd. | S Sale | 2020-07-27 | 2020-07-28 | 141 | $23.51 | $3.3K | 7,355 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2020-07-26 | 2020-07-28 | 417 | — | $0 | 2,500 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2020-07-26 | 2020-07-28 | 417 | — | $0 | 7,496 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2020-05-20 | 2020-05-20 | 1,041 | — | $0 | 5,208 | SEC↗ |
| URGN UroGen Pharma Ltd. | S Sale | 2020-05-20 | 2020-05-20 | 358 | $25.07 | $9.0K | 7,079 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2020-05-20 | 2020-05-20 | 1,041 | — | $0 | 7,437 | SEC↗ |
| URGN UroGen Pharma Ltd. | S Sale | 2020-04-27 | 2020-04-28 | 141 | $24.35 | $3.4K | 6,396 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2020-04-26 | 2020-04-28 | 417 | — | $0 | 2,917 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2020-04-26 | 2020-04-28 | 417 | — | $0 | 6,537 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2020-02-20 | 2020-02-24 | 1,042 | — | $0 | 6,249 | SEC↗ |
| URGN UroGen Pharma Ltd. | S Sale | 2020-02-20 | 2020-02-24 | 360 | $29.68 | $10.7K | 6,120 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2020-02-20 | 2020-02-24 | 1,042 | — | $0 | 6,480 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2020-01-31 | 2020-02-04 | 6,000 | — | $0 | 6,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2020-01-31 | 2020-02-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | S Sale | 2020-01-27 | 2020-01-28 | 667 | $29.28 | $19.5K | 4,438 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2020-01-26 | 2020-01-28 | 1,666 | — | $0 | 3,334 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2020-01-26 | 2020-01-28 | 1,666 | — | $0 | 5,105 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2019-11-20 | 2019-11-22 | 1,042 | — | $0 | 7,291 | SEC↗ |
| URGN UroGen Pharma Ltd. | S Sale | 2019-11-20 | 2019-11-22 | 354 | $28.41 | $10.1K | 3,439 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2019-11-20 | 2019-11-22 | 1,042 | — | $0 | 3,793 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2019-08-20 | 2019-08-22 | 4,167 | — | $0 | 8,333 | SEC↗ |
| URGN UroGen Pharma Ltd. | S Sale | 2019-08-20 | 2019-08-22 | 1,416 | $33.07 | $46.8K | 2,751 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2019-08-20 | 2019-08-22 | 4,167 | — | $0 | 4,167 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2019-01-26 | 2019-01-29 | 5,000 | — | $0 | 5,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2019-01-26 | 2019-01-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | D To issuer deriv | 2018-02-13 | 2018-02-13 | 150,000 | $7.10 | $1.06M | 0 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | D To issuer | 2018-02-13 | 2018-02-13 | 263 | $18.00 | $4.7K | 0 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2017-12-31 | 2018-01-12 | 263 | $9.10 | $2.4K | 263 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award | 2017-09-30 | 2018-01-12 | 131 | $9.10 | $1.2K | 131 | SEC↗ |
| SCMP Sucampo Pharmaceuticals, I | A Award deriv | 2017-03-20 | 2017-03-22 | 150,000 | — | $0 | 150,000 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award deriv | 2015-08-20 | 2015-08-24 | 38,484 | — | $0 | 38,484 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award | 2015-08-20 | 2015-08-24 | 15,341 | — | $0 | 29,706 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award deriv | 2015-03-09 | 2015-03-11 | 50,000 | — | $0 | 0 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award deriv | 2014-08-14 | 2014-08-18 | 87,895 | — | $0 | 87,895 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award | 2014-08-14 | 2014-08-18 | 15,813 | — | $0 | 15,813 | SEC↗ |
| IMMU IMMUNOMEDICS INC | A Award deriv | 2013-09-03 | 2013-09-04 | 75,000 | — | $0 | 75,000 | SEC↗ |